Risk 25 firms of the future: TriOptima

In the balance

Per Sjöberg, TriOptima

There is still room for big ideas in the over-the-counter derivatives market, but it’s a sign of the times that one of this year’s most creative new ventures is, essentially, an attempt to synthetically clear uncleared OTC products.

TriOptima calls the service triBalance, and it has been a hit with banks, says Per Sjöberg, TriOptima’s Stockholm-based chief executive. “We’ve been pleasantly surprised by the interest in this service,” he says. “The dealer community obviously regards rebalancing

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

If you already have an account, please sign in here.


Want to know what’s included in our free membership? Click here

This address will be used to create your account

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: